Christopher O’DonnellGlobal Head Cardiovascular and Metabolism Translational Medicine at Novartis BioMedical ResearchSpeaker
Agenda Sessions
The Role of siRNA and Lp(a) in Cardiovascular Risk Assessment and Clinical Practice
, 13:50View Session